Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthma.
D000293:Adolescent; D000336:Aerosols; D000605:Amino Alcohols / Q000494:pharmacology*; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002648:Child; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D010991:Plethysmography; D011674:Pulse / Q000187:drug effects; D012118:Resorcinols / Q000494:pharmacology*; D013147:Spirometry; D014797:Vital Capacity / Q000187:drug effects
D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol; D007545:Isoproterenol